Associate Chief Physician, Associate Professor and Master’s Supervisor in the Department of Lymphoma, Peking University Cancer Hospital. Visiting Scholar at the University of Texas MD Anderson Cancer Center. His professional focus covers the diagnosis and treatment of lymphoma, autologous hematopoietic stem‑cell transplantation and cellular immunotherapy. He has participated in multiple domestic and international clinical trials of new drugs, and possesses extensive experience in lymphoma therapies as well as the application of novel drugs and approaches across various lymphoma‑related fields. He has undertaken numerous research projects including those supported by the National Natural Science Foundation of China, Beijing Natural Science Foundation, Cultivation Program of Beijing Hospital Administration, and Research‑Oriented Outstanding Clinical Research Program of Beijing Municipal Health Commission. He has published more than ten SCI papers as first author and co‑author in journals such as Leukemia, Am J Hematol and Blood Advances, and contributed to monographs including Lymphoma of the Central Nervous System.